Research study Program year 2023 Source: CMS Open Payments

Biomarker Ang 2 Inhibitor Study

Research payments

$1,847,073

221 payments

Through program year 2023, $1,847,073 in research payments was reported against Biomarker Ang 2 Inhibitor Study, across 221 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$221,837	56
2022	Research	$1,183,604	118
2021	Research	$441,632	47

Breakdown

Who paid Research payments · program years 2021–2023

Genentech, Inc. $1,847,073 221 payments

Who received the money Research payments · program years 2021–2023

Maturi, Raj K. , MD Organisation paid for research $270,435 16 payments
Vitreoretinal Consultants Organisation paid for research $180,841 24 payments
Strategic Clinical Research Group, LLc Organisation paid for research $179,474 16 payments
Long Island Vitreoretinal Consultants Organisation paid for research $152,870 10 payments
Retina Research Institute, LLC Organisation paid for research $117,417 12 payments
University Retina & MacUla Associates Pc Organisation paid for research $116,711 7 payments
Long Island Vitreoretinal Consultants 53643 Organisation paid for research $98,783 8 payments
Retina Research Institute LLC Organisation paid for research $96,683 7 payments
Austin Research Center For Retina, Pllc; Organisation paid for research $78,560 13 payments
Northwestern University Organisation paid for research $67,735 10 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.